KLA Corporation
KLA Corporation (KLAC) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for KLA Corporation (KLAC), covering cash flow, earnings, and balance sheets.
KLA Corporation (KLAC) Income Statement & Financial Overview
Review KLA Corporation KLAC income statement with detailed quarterly and annual figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $3.06B | $3.08B | $2.84B | $2.57B |
| Cost of Revenue | $1.18B | $1.22B | $1.15B | $974.05M |
| Gross Profit | $1.89B | $1.86B | $1.69B | $1.59B |
| Gross Profit Ratio | $0.62 | $0.60 | $0.60 | $0.62 |
| R&D Expenses | $338.04M | $346.16M | $323.14M | $323.53M |
| SG&A Expenses | $248.91M | $267.08M | $251.04M | $216.12M |
| Operating Expenses | $586.95M | $613.24M | $574.19M | $539.65M |
| Total Costs & Expenses | $1.76B | $1.83B | $1.72B | $1.51B |
| Interest Income | $0.00 | $0.00 | $0.00 | $160.69M |
| Interest Expense | $71.89M | $74.98M | $82.17M | $82.84M |
| Depreciation & Amortization | -$35.93M | $40.94M | $95.82M | $101.001M |
| EBITDA | $1.30B | $1.24B | $1.26B | $1.13B |
| EBITDA Ratio | $0.42 | $0.40 | $0.44 | $0.44 |
| Operating Income | $1.30B | $1.24B | $1.12B | $1.05B |
| Operating Income Ratio | $0.42 | $0.40 | $0.39 | $0.41 |
| Other Income/Expenses (Net) | -$35.96M | -$269.62M | -$41.24M | -$107.48M |
| Income Before Tax | $1.26B | $972.53M | $1.08B | $945.04M |
| Income Before Tax Ratio | $0.41 | $0.32 | $0.38 | $0.37 |
| Income Tax Expense | $176.02M | $148.002M | $132.84M | $108.60M |
| Net Income | $1.09B | $824.53M | $945.85M | $836.45M |
| Net Income Ratio | $0.36 | $0.27 | $0.33 | $0.33 |
| EPS | $8.21 | $6.18 | $7.05 | $6.22 |
| Diluted EPS | $8.16 | $6.13 | $7.01 | $6.18 |
| Weighted Avg Shares Outstanding | $132.61M | $133.33M | $134.13M | $134.46M |
| Weighted Avg Shares Outstanding (Diluted) | $133.30M | $134.41M | $134.86M | $135.34M |
The company's financials show resilient growth, with revenue advancing from $2.57B in Q4 2024 to $3.06B in Q3 2025. Gross profit remained healthy with margins at 62% in Q3 2025 compared to 62% in Q4 2024. Operating income hit $1.30B last quarter, sustaining a consistent 42% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.30B. Net income rose to $1.09B, while earnings per share reached $8.21. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan